RT Journal Article
SR Electronic
T1 Modifiable Risk Factors for Stroke, Dementia, and Late-Life Depression: A Systematic Review and DALY Weighted Risk Factors for a Composite Outcome
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.08.24309905
DO 10.1101/2024.07.08.24309905
A1 Senff, Jasper R.
A1 Tack, Reinier W.P.
A1 Mallick, Akashleena
A1 Gutierrez-Martinez, Leidys
A1 Duskin, Jonathan
A1 Kimball, Tamara N.
A1 Chemali, Zeina
A1 Newhouse, Amy
A1 Kourkoulis, Christina
A1 Rivier, Cyprien
A1 Falcone, Guido J
A1 Sheth, Kevin N
A1 Lazar, Ronald M
A1 Ibrahim RN, Sarah
A1 Pikula, Aleksandra
A1 Tanzi, Rudolph E.
A1 Fricchione, Gregory
A1 Brouwers, H. Bart
A1 Rinkel, Gabrël J.E.
A1 Yechoor, Nirupama
A1 Rosand, Jonathan
A1 Anderson, Christopher D.
A1 Singh, Sanjula D.
YR 2024
UL http://medrxiv.org/content/early/2024/07/08/2024.07.08.24309905.abstract
AB Background At least 60% of stroke, 40% of dementia, and 35% of late-life depression (LLD) are attributable to modifiable risk factors, with great overlap due to a shared underlying pathophysiology. This study aims to systematically identify overlapping risk factors for these diseases and calculate their relative impact on a composite outcome.Methods A systematic literature review was performed in Pubmed, Embase, and PsycInfo, between January 2000 and September 2023. We included meta-analyses reporting effect sizes of modifiable risk factors on the incidence of stroke, dementia, and/or LLD. The most relevant meta-analyses were selected, and Disability Adjusted Life Year (DALY) weighted beta-coefficients were calculated for a composite outcome. The beta-coefficients were then normalized to assess relative impact.Results Our search yielded 182 meta-analyses meeting the inclusion criteria, of which 59 were selected to calculate DALY-weighted risk factors for a composite outcome. Identified risk factors included alcohol use (normalized beta-coefficient highest category: -20), blood pressure (87), BMI (42), fasting plasma glucose (57), total cholesterol (14), leisure time cognitive activity (-54), depressive symptoms (34), diet (27), hearing loss (35), kidney function (60), pain (25), physical activity (-34), purpose in life (-30), sleep (44), smoking (58), social engagement (32), and stress (32).Discussion This study identified overlapping modifiable risk factors and calculated the relative impact of these factors on the risk of a composite outcome of stroke, dementia, and LLD. These findings could guide preventative strategies and serve as an empirical foundation for future development of tools that can empower people to reduce their risk of these diseases.Funding US National Institutes of Health and American Heart Association.Competing Interest StatementC.D.A. receives sponsored research support from the US National Institutes of Health, the American Heart Association, and Bayer AG, and has consulted for ApoPharma. M.C. is supported by the Wellcome Trust [grant number 205339/Z/16/Z]. JR receives sponsored research support from the US National Institutes of Health and the American Heart Association, receives payments for consulting and expert testimony from the National Football League, consulting for Eli Lilly, and has a leadership or fiduciary role at Columbia University and Lancet Neurology. G.F. receives sponsored research support from the National Institute of Mental Health Clinical Global Mental Health Research T32 Fellowship, receives royalties or licenses from Johns Hopkins University Press, University of Chicago Press, Belvoir Press, and the American Psychiatric Press, is on a Data Safety Monitoring Board or Advisory Board of Healthy Hearts Healthy Minds DSMB, is a Board of Directors member at the Rosalynn Carter Institute, and has stock or stock options from Revival Therapeutics Consultant.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=476939 Funding StatementFunding: US National Institutes of Health and American Heart Association.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This manuscript only utilized previously published data. All data employed in this study, including the intermediate calculations, are comprehensively presented in the supplementary tables accompanying this manuscript.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis manuscript only utilized previously published data. All data employed in this study, including the intermediate calculations, are comprehensively presented in the supplementary tables accompanying this manuscript. Should there be any inquiries or requests for further clarification regarding the data, please contact the corresponding author. https://www.zotero.org/groups/5402286/sroma/collections/PY6XGESM